Show simple item record

dc.contributor.authorMacDonald, AJ
dc.contributor.authorPye, KR
dc.contributor.authorBeall, C
dc.contributor.authorEllacott, KLJ
dc.date.accessioned2023-09-18T14:03:38Z
dc.date.issued2023-06-09
dc.date.updated2023-09-18T13:52:57Z
dc.description.abstractThe dorsal vagal complex (DVC) regulates diverse aspects of physiology including food intake and blood glucose homeostasis. Astrocytes play an active role in regulating DVC function and, by extension, physiological parameters. DVC astrocytes in ex vivo slices respond to low tissue glucose. The response of neurons to low glucose is conditional on intact astrocyte signalling in slice preparations, suggesting astrocytes are primary sensors of glucose deprivation (glucoprivation). Based on these published findings we hypothesised that in vivo DVC astrocyte manipulation with chemogenetics would be sufficient to alter physiological responses that control blood glucose. We found that 2-h after systemic 2-DG-induced glucoprivation there were no observable changes in morphology of glial fibrillary acidic protein (GFAP)-immunoreactive DVC cells, specifically those in the nucleus of the solitary tract (NTS). Chemogenetic activation of DVC astrocytes was sufficient to suppress nocturnal food intake by reducing both meal size and meal number and this manipulation also suppressed 2-DG-induced glucoprivic food intake. Chemogenetic activation of DVC astrocytes did not increase basal blood glucose nor protect against insulin-induced hypoglycaemia. In male mice, chemogenetic DVC astrocyte activation did not alter glucose tolerance. In female mice, the initial glucose excursion was reduced in a glucose tolerance test, suggesting enhanced glucose absorption. Based on our data and published work, we propose that DVC astrocytes may play an indispensable homeostatic role, that is, are necessary to maintain the function of glucoregulatory neuronal circuitry, but alone their bulk activation is not sufficient to result in adaptive glucoregulatory responses. It is possible that there are state-dependent effects and/or DVC astrocyte subsets that have this specialised role, but this was unresolvable using the experimental approaches employed here.en_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.format.extente13315-
dc.format.mediumPrint-Electronic
dc.identifier.citationVol. 35(8), article e13315en_GB
dc.identifier.doihttps://doi.org/10.1111/jne.13315
dc.identifier.grantnumber19/0006035en_GB
dc.identifier.urihttp://hdl.handle.net/10871/134022
dc.identifierORCID: 0000-0002-4263-0866 (Beall, Craig)
dc.identifierScopusID: 36175475800 (Beall, Craig)
dc.identifierORCID: 0000-0001-5261-7465 (Ellacott, Kate LJ)
dc.identifierScopusID: 6603078325 (Ellacott, Kate LJ)
dc.language.isoenen_GB
dc.publisherWiley / British Society for Neuroendocrinologyen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/37370201en_GB
dc.rights© 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectastrocyteen_GB
dc.subjectbrainstemen_GB
dc.subjectfeedingen_GB
dc.subjectglucoprivicen_GB
dc.subjecthypoglycaemiaen_GB
dc.titleImpact of chemogenetic activation of dorsal vagal complex astrocytes in mice on adaptive glucoregulatory responsesen_GB
dc.typeArticleen_GB
dc.date.available2023-09-18T14:03:38Z
dc.identifier.issn0953-8194
exeter.article-numberARTN e13315
exeter.place-of-publicationUnited States
dc.descriptionThis is the final version. Available on open access from Wiley via the DOI in this recorden_GB
dc.descriptionData availability statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.en_GB
dc.identifier.eissn1365-2826
dc.identifier.journalJournal of Neuroendocrinologyen_GB
dc.relation.ispartofJ Neuroendocrinol, 35(8)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-05-31
dc.rights.licenseCC BY
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-06-09
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-09-18T14:01:39Z
refterms.versionFCDVoR
refterms.dateFOA2023-09-18T14:03:39Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-06-09


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.